Cargando…

Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study

There is need for a brief but comprehensive objective assessment tool to help clinicians evaluate relapse symptoms in patients with multiple sclerosis (MS) and their impact on daily functioning, as well as response to treatment. The 2-part Assessing Relapse in Multiple Sclerosis (ARMS) questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrin Ross, Amy, Williamson, Alona, Smrtka, Jennifer, Flemming Tracy, Tracy, Saunders, Carol, Easterling, Constance, Niewoehner, John, Mutschler, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677606/ https://www.ncbi.nlm.nih.gov/pubmed/23766909 http://dx.doi.org/10.1155/2013/470476

Ejemplares similares

Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone
por: Ross, Amy Perrin, et al.
Publicado: (2013)

Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis
por: Kramer, John, et al.
Publicado: (2023)

Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis
por: Healy, Brian C., et al.
Publicado: (2013)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis
por: Tynyakov-Samra, Evgenia, et al.
Publicado: (2011)

Phonological Fluency Strategy of Switching Differentiates Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Patients
por: Messinis, L., et al.
Publicado: (2013)

Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
por: Hatam, Nahid, et al.
Publicado: (2016)

Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study
por: Irish, Amanda K, et al.
Publicado: (2017)

Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication
por: Van Reenen, Eva, et al.
Publicado: (2019)

Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
por: Ross, Amy Perrin, et al.
Publicado: (2023)

Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis
por: Sainaghi, P. P., et al.
Publicado: (2013)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
por: Ordoñez-Boschetti, Laura, et al.
Publicado: (2015)

Supporting successful recruitment in a randomized control trial comparing clinic and home-based exercise among adults with multiple sclerosis
por: Tracy, Tracy Flemming, et al.
Publicado: (2022)

Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis
por: Hellwig, Kerstin, et al.
Publicado: (2006)

The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives
por: Hussain, Rehana Z, et al.
Publicado: (2022)

Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
por: Ordoñez-Boschetti, Laura, et al.
Publicado: (2015)

Smoking Cessation Considerations for People with Multiple Sclerosis
por: Brooker, Christa, et al.
Publicado: (2020)

Validity and reliability of the Patient Health Questionnaire-8 in Swedish for individuals with systemic sclerosis
por: Mattsson, Malin, et al.
Publicado: (2020)

Physical activity is related to disease severity and fatigue, but not to relapse rate in persons with relapsing remitting multiple sclerosis – a self-reported questionnaire based study
por: Schlagheck, Marit L., et al.
Publicado: (2023)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

Factors Involved in Relapse of Multiple Sclerosis
por: Kamel, Fatemah Omar
Publicado: (2019)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis—A Pilot Study
por: Rzepiński, Łukasz, et al.
Publicado: (2021)

Corpus Callosum Microstructural Changes Correlate with Cognitive Dysfunction in Early Stages of Relapsing-Remitting Multiple Sclerosis: Axial and Radial Diffusivities Approach
por: Rimkus, Carolina de Medeiros, et al.
Publicado: (2011)

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013)

Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
por: Shaygannejad, Vahid, et al.
Publicado: (2012)

The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis
por: van der Hiele, Karin, et al.
Publicado: (2015)

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)
por: Klotz, Luisa, et al.
Publicado: (2015)

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis
por: Castellazzi, Gloria, et al.
Publicado: (2018)

Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland
por: Meijboom, Rozanna, et al.
Publicado: (2022)

Jacksonian seizure as the relapse symptom of multiple sclerosis
por: Najafi, Mohammad Reza, et al.
Publicado: (2013)

Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Predictors of severity and outcome of multiple sclerosis relapses
por: Hosny, Hassan Saad, et al.
Publicado: (2023)

The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care
por: Asano, Miho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fm0sk6piio4mtki98e5gm7kmup